Volume 24, Number 9—September 2018
Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms
|Type of multidrug-resistant organism|
|Methicillin-resistant Staphylococcus aureus||177 (78)|
|Vancomycin-resistant Enterococci||18 (8)|
|Extended-spectrum β-lactamase||9 (4)|
|Klebsiella pneumoniae carbapenemase-producing Enterobactericeae||5 (2)|
|Long-term care facilities||61 (27)|
|Paramedical facilities||23 (10)|
|Home-care facilities||14 (6)|
|Rehabilitation centers||5 (2)|
|Carriage among healthcare workers||50 (22)|
|Social interaction of healthcare workers||32 (14)|
*In the Netherlands, 25 regional Public Health Services (PHS) are in charge of communicable disease control. Healthcare institutions such as hospitals and nursing homes have a responsibility to detect, monitor, and control outbreaks within their facility and report these to the PHS. The PHS assists healthcare institutions and professionals and provides advice on the basis of national guidelines. In turn, the Centre for Infectious Disease Control of the National Institute of Public Health and the Environment (RIVM) acts as national public health authority; it develops and publishes national guidelines and offers support in outbreak management including a 24-hour consultation helpdesk for PHS and other health professionals. The center is consulted by PHS professionals >1,000 times/y about a variety of cases of notifiable diseases, outbreaks, and incidents that occur in the community (15,17,18). Since 2008, all consultations have been anonymously registered in a database. During the 8-year study period, RIVM registered 227 consultations associated with carriage of multidrug-resistant organisms that needed national guidance.
- World Health Organization. Global action plan on antimicrobial resistance. Report no. WHA68/2015/REC/1. Geneva: The Organization; 2015.
- Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005;33:309–13.
- Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(Suppl 2):S65–164.
- Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(Suppl 2):S165–93.
- Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584–99.
- Leibovici L, Paul M. Ethical dilemmas in antibiotic treatment: focus on the elderly. Clin Microbiol Infect. 2015;21:27–9.
- Leibovici L, Paul M, Ezra O. Ethical dilemmas in antibiotic treatment. J Antimicrob Chemother. 2012;67:12–6.
- Littmann J. Antimicrobial resistance and distributive justice [doctoral thesis]. London: University College London; 2014.
- Littmann J, Viens AM. The ethical significance of antimicrobial resistance. Public Health Ethics. 2015;8:209–24.
- Millar M. Can antibiotic use be both just and sustainable... or only more or less so? J Med Ethics. 2011;37:153–7.
- Millar M. Constraining the use of antibiotics: applying Scanlon’s contractualism. J Med Ethics. 2012;38:465–9.
- Selgelid MJ. Ethics and drug resistance. Bioethics. 2007;21:218–29.
- Abad C, Fearday A, Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect. 2010;76:97–102.
- Barratt RL, Shaban R, Moyle W. Patient experience of source isolation: lessons for clinical practice. Contemp Nurse. 2011;39:180–93.
- Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control. 2009;37:85–93.
- Mutsonziwa GA, Green J. Colonised and isolated: a qualitative metasynthesis of patients’ experiences of being infected with multiple drug resistant organisms and subsequent isolation. Healthc Infect. 2011;16:147–55.
- Bijkerk P, Fanoy EB, van der Sande MA. When should notification of an infectious disease be mandatory? A decision aid to determine whether mandatory notification is justified [in Dutch]. Ned Tijdschr Geneeskd. 2016;160:A9768.https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27050495&dopt=Abstract
- van Vliet JA, Haringhuizen GB, Timen A, Bijkerk P. Changes in the duty of notification of infectious diseases via the Dutch Public Health Act [in Dutch]. Ned Tijdschr Geneeskd. 2009;153:B79.https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19818190&dopt=Abstract
- Altorf-van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, et al.; The National AMR Surveillance Study Group. National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands. Euro Surveill. 2017;22.
- de Greeff SC, Mouton JW. NethMap 2017: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands/MARAN 2017: monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2016 [cited 2018 Jun 26]. https://www.rivm.nl/Documenten_en_publicaties/Wetenschappelijk/Rapporten/2017/Juni/NethMap_2017_Consumption_of_antimicrobial_agents_and_antimicrobial_resistance_among_medically_important_bacteria_in_the_Netherlands_MARAN_2017_Monitoring_of_antimicrobial_resistance_and_antibiotic_usage_in_animals_in_the_Netherlands_in_2016
- The European Centre for Disease Prevention and Control. Data from the ECDC Surveillance Atlas—antimicrobial resistance [cited 2018 Feb 25]. https://ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc
- Verweij M. Infectious disease control, Section 2, Chapter 6. In: Dawson A, editor. Public Health Ethics: Key Concepts and Issues in Policy and Practice. New York: Cambridge University Press; 2011. p. 100–17.
- Selgelid MJ. Ethics and infectious disease. Bioethics. 2005;19:272–89.
- Barrett DH, Ortmann LW, Dawson A, Saenz C, Reis A, Bolan GA. Public health ethics: cases spanning the globe. New York: Springer; 2016.
- Battin MP, Francis LP, Jacobson JA, Smith CB. Characteristics of infectious disease that raise distinctive challenges for bioethics. In: Battin MP, Francis LP, Jacobson JA, Smith CB, editors. The patient as victim and vector: ethics and infectious disease. New York: Oxford University Press; 2009. p. 26–40.
- Blais CM, White JL. Bioethics in practice—a quarterly column about medical ethics: Ebola and medical ethics—ethical challenges in the management of contagious infectious diseases. Ochsner J. 2015;15:5–7.https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25829872&dopt=Abstract
- Daha TJ, Bilkert-Mooiman MA, Ballemans C, Frijstein G, Keeman JN, de Man RA, et al. Hepatitis B virus infected health care workers in The Netherlands, 2000-2008. Eur J Clin Microbiol Infect Dis. 2009;28:1041–4.
- Jarrell AS, Kruer RM, Berescu LD, Pronovost PJ, Trivedi JB. Factors associated with in-hospital mortality among critically ill surgical patients with multidrug-resistant Gram-negative infections. J Crit Care. 2018;43:321–6.
- Patel SJ, Oliveira AP, Zhou JJ, Alba L, Furuya EY, Weisenberg SA, et al. Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. Am J Infect Control. 2014;42:626–31.
- Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect. 2013;66:401–14.
- Washer P, Joffe H. The “hospital superbug”: social representations of MRSA. Soc Sci Med. 2006;63:2141–52.
- Weiss MG, Ramakrishna J, Somma D. Health-related stigma: rethinking concepts and interventions. Psychol Health Med. 2006;11:277–87.
- Rump B, De Boer M, Reis R, Wassenberg M, Van Steenbergen J. Signs of stigma and poor mental health among carriers of MRSA. J Hosp Infect. 2017;95:268–74.
- Van Brakel WH. Measuring health-related stigma—a literature review. Psychol Health Med. 2006;11:307–34.
- Scambler G, Heijnders M, van Brakel WH; ICRAAS. Understanding and tackling health-related stigma. Psychol Health Med. 2006;11:269–70.
- Kass NE. An ethics framework for public health. Am J Public Health. 2001;91:1776–82.
- Petrini C, Ricciardi G. Ethical issues in public health surveillance: drawing inspiration from ethical frameworks. Ann Ist Super Sanita. 2015;51:270–6.https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26783212&dopt=Abstract
- Schröder-Bäck P, Duncan P, Sherlaw W, Brall C, Czabanowska K. Teaching seven principles for public health ethics: towards a curriculum for a short course on ethics in public health programmes. BMC Med Ethics. 2014;15:73.
- D’Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-M-type β-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol. 2013;303:305–17.
- Picker Institute. Principles of patient-centered care [cited 2018 Feb 25]. http://pickerinstitute.org/about/picker-principles/
- Entwistle VA, Watt IS. Treating patients as persons: a capabilities approach to support delivery of person-centered care. Am J Bioeth. 2013;13:29–39.
- Stanford Encyclopedia of Philosophy Archive. The capability approach [cited 2018 Feb 25] https://plato.stanford.edu/archives/win2016/entries/capability-approach
- Nussbaum MC. In defense of universal values. In: Nussbaum MC, editor. Women and Human Development. Cambridge: Cambridge University Press; 2000. p. 24–100.
- Sen A. Equality of what? In: McMurrin S, editor. Tanner Lectures on Human Values, Vol 1. Cambridge: Cambridge University Press; 1980.
- Millar MR. A capabilities perspective on healthcare associated infection. Am J Bioeth. 2013;13:53–4.